
Drugs IPOs Depend o...


| Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 427.05M | 398.93M | 360.42M | 319.02M |
| Operating Gains/Losses | -245.00K | -4.28M | 732.00K | 8.97M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -87.43M | -41.58M | -12.87M | -86.01M |
| (Increase) Decrease in Inventories | -42.46M | -42.24M | -53.33M | -39.58M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 19.28M | 35.52M | 2.96M | 6.04M |
| (Decrease) Increase In Other Current Liabilities | 122.07M | 18.28M | 63.40M | 57.18M |
| (Increase) Decrease In Other Working Capital | -15.54M | -12.41M | -10.59M | -22.13M |
| Other Non-Cash Items | 58.45M | 46.00M | 45.42M | 41.83M |
| Net Cash From Continuing Operations | 492.78M | 472.78M | 460.79M | 304.43M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 492.78M | 472.78M | 460.79M | 304.43M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -61.10M | -70.93M | -67.54M | -62.56M |
| Acquisitions | -28.24M | -9.12M | -1.80M | -2.55M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | -2.45M | -5.08M | -6.06M | -10.29M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -122.30M | -117.93M | -74.82M | -77.91M |
| Issuance of Debt | -26.40M | 161.40M | 15.60M | 4.17M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 60.33M | 137.70M | 99.50M | 37.46M |
| Repayment of Long-Term Debt | -9.88M | -7.26M | -9.00M | -7.99M |
| Repurchase of Capital Stock | -257.44M | -505.28M | -497.50M | -101.48M |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -1.29M | -97.88M | -30.77M | -3.44M |
| Net Cash From Financing Activities | -234.68M | -311.34M | -422.18M | -71.28M |
| Effect of Exchange Rate Changes | 4.31M | 724.00K | 2.90M | 977.00K |
| Net Change in Cash & Cash Equivalents | 140.11M | 44.24M | -33.31M | 156.22M |